Effects of burn serum on myocardial inflammation and function

Jureta W. Horton, David L. Maass, D. Jean White, Billy Sanders, Joseph Murphy

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Large cutaneous burns are clearly recognized to produce acute myocardial contractile dysfunction. This study used a model of burn serum challenge in either primary cardiomyocyte cultures or isolated perfused hearts to examine several aspects of burn-serum-related contractile dysfunction as well as myocardial inflammatory responses. Despite the absence of detectable LPS in burn serum, pretreating isolated cells or perfused hearts with recombinant bactericidal permeability-increasing protein (rBPI21) prevented both the inflammatory cytokine cascade and the cardiac contractile dysfunction induced by burn serum treatment of myocytes or ventricular muscle preparations. Our finding that anti-TNF strategies applied to isolated myocytes or hearts before burn serum challenge prevented myocardial inflammation and contractile dysfunction suggested that LPS or LPS-like factors may require the action of second messengers such as TNF-α and IL-1β to mediate LPS-related myocardial depressant effects. Our finding that experimental approaches neutralizing circulating LPS provided cardioprotection suggested that bacterial endotoxin or LPS-like molecules contribute, in part, to burn-related myocardial contractile dysfunction.

Original languageEnglish (US)
Pages (from-to)438-445
Number of pages8
JournalShock
Volume22
Issue number5
DOIs
StatePublished - Nov 2004

Fingerprint

Inflammation
Burns
Serum
Muscle Cells
Anti-Arrhythmia Agents
Second Messenger Systems
Interleukin-1
Cardiac Myocytes
Endotoxins
Cytokines
Muscles
Skin

Keywords

  • Adult rats
  • Inflammatory cytokines
  • Isolated cardiomyocytes
  • Langendorff-perfused hearts
  • rBPI

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Physiology

Cite this

Effects of burn serum on myocardial inflammation and function. / Horton, Jureta W.; Maass, David L.; White, D. Jean; Sanders, Billy; Murphy, Joseph.

In: Shock, Vol. 22, No. 5, 11.2004, p. 438-445.

Research output: Contribution to journalArticle

Horton, JW, Maass, DL, White, DJ, Sanders, B & Murphy, J 2004, 'Effects of burn serum on myocardial inflammation and function', Shock, vol. 22, no. 5, pp. 438-445. https://doi.org/10.1097/01.shk.0000142252.31006.c5
Horton, Jureta W. ; Maass, David L. ; White, D. Jean ; Sanders, Billy ; Murphy, Joseph. / Effects of burn serum on myocardial inflammation and function. In: Shock. 2004 ; Vol. 22, No. 5. pp. 438-445.
@article{6c698cd7f23e490dab0ff1ec9318fc1d,
title = "Effects of burn serum on myocardial inflammation and function",
abstract = "Large cutaneous burns are clearly recognized to produce acute myocardial contractile dysfunction. This study used a model of burn serum challenge in either primary cardiomyocyte cultures or isolated perfused hearts to examine several aspects of burn-serum-related contractile dysfunction as well as myocardial inflammatory responses. Despite the absence of detectable LPS in burn serum, pretreating isolated cells or perfused hearts with recombinant bactericidal permeability-increasing protein (rBPI21) prevented both the inflammatory cytokine cascade and the cardiac contractile dysfunction induced by burn serum treatment of myocytes or ventricular muscle preparations. Our finding that anti-TNF strategies applied to isolated myocytes or hearts before burn serum challenge prevented myocardial inflammation and contractile dysfunction suggested that LPS or LPS-like factors may require the action of second messengers such as TNF-α and IL-1β to mediate LPS-related myocardial depressant effects. Our finding that experimental approaches neutralizing circulating LPS provided cardioprotection suggested that bacterial endotoxin or LPS-like molecules contribute, in part, to burn-related myocardial contractile dysfunction.",
keywords = "Adult rats, Inflammatory cytokines, Isolated cardiomyocytes, Langendorff-perfused hearts, rBPI",
author = "Horton, {Jureta W.} and Maass, {David L.} and White, {D. Jean} and Billy Sanders and Joseph Murphy",
year = "2004",
month = "11",
doi = "10.1097/01.shk.0000142252.31006.c5",
language = "English (US)",
volume = "22",
pages = "438--445",
journal = "Shock",
issn = "1073-2322",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Effects of burn serum on myocardial inflammation and function

AU - Horton, Jureta W.

AU - Maass, David L.

AU - White, D. Jean

AU - Sanders, Billy

AU - Murphy, Joseph

PY - 2004/11

Y1 - 2004/11

N2 - Large cutaneous burns are clearly recognized to produce acute myocardial contractile dysfunction. This study used a model of burn serum challenge in either primary cardiomyocyte cultures or isolated perfused hearts to examine several aspects of burn-serum-related contractile dysfunction as well as myocardial inflammatory responses. Despite the absence of detectable LPS in burn serum, pretreating isolated cells or perfused hearts with recombinant bactericidal permeability-increasing protein (rBPI21) prevented both the inflammatory cytokine cascade and the cardiac contractile dysfunction induced by burn serum treatment of myocytes or ventricular muscle preparations. Our finding that anti-TNF strategies applied to isolated myocytes or hearts before burn serum challenge prevented myocardial inflammation and contractile dysfunction suggested that LPS or LPS-like factors may require the action of second messengers such as TNF-α and IL-1β to mediate LPS-related myocardial depressant effects. Our finding that experimental approaches neutralizing circulating LPS provided cardioprotection suggested that bacterial endotoxin or LPS-like molecules contribute, in part, to burn-related myocardial contractile dysfunction.

AB - Large cutaneous burns are clearly recognized to produce acute myocardial contractile dysfunction. This study used a model of burn serum challenge in either primary cardiomyocyte cultures or isolated perfused hearts to examine several aspects of burn-serum-related contractile dysfunction as well as myocardial inflammatory responses. Despite the absence of detectable LPS in burn serum, pretreating isolated cells or perfused hearts with recombinant bactericidal permeability-increasing protein (rBPI21) prevented both the inflammatory cytokine cascade and the cardiac contractile dysfunction induced by burn serum treatment of myocytes or ventricular muscle preparations. Our finding that anti-TNF strategies applied to isolated myocytes or hearts before burn serum challenge prevented myocardial inflammation and contractile dysfunction suggested that LPS or LPS-like factors may require the action of second messengers such as TNF-α and IL-1β to mediate LPS-related myocardial depressant effects. Our finding that experimental approaches neutralizing circulating LPS provided cardioprotection suggested that bacterial endotoxin or LPS-like molecules contribute, in part, to burn-related myocardial contractile dysfunction.

KW - Adult rats

KW - Inflammatory cytokines

KW - Isolated cardiomyocytes

KW - Langendorff-perfused hearts

KW - rBPI

UR - http://www.scopus.com/inward/record.url?scp=8144230875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8144230875&partnerID=8YFLogxK

U2 - 10.1097/01.shk.0000142252.31006.c5

DO - 10.1097/01.shk.0000142252.31006.c5

M3 - Article

VL - 22

SP - 438

EP - 445

JO - Shock

JF - Shock

SN - 1073-2322

IS - 5

ER -